Market Cap 15.72M
Revenue (ttm) 11.20M
Net Income (ttm) 10,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.09%
Debt to Equity Ratio 0.00
Volume 26,700
Avg Vol 33,576
Day's Range N/A - N/A
Shares Out 5.42M
Stochastic %K 33%
Beta 1.29
Analysts Sell
Price Target $7.38

Company Profile

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1111 (TLANDO XR), a next-generation long-acting oral product candidate for TRT; LPCN 1148, a novel prodrug of testosterone and testosterone...

Industry: Biotechnology
Sector: Healthcare
Phone: 801 994 7383
Fax: 801 994 7388
Address:
675 Arapeen Drive, Suite 202, Salt Lake City, United States
Pedelco
Pedelco Oct. 27 at 4:51 PM
$LPCN come ✌️
0 · Reply
veseli
veseli Oct. 24 at 2:37 PM
$LPCN Yesterdays prophecy coming true
2 · Reply
veseli
veseli Oct. 15 at 7:28 PM
$LPCN Dead in the water 🤷
2 · Reply
dbatech99
dbatech99 Oct. 13 at 7:59 PM
$AMD Here are the only 2 stinkers I have... $PTON and $LPCN I don't have a large position of each... but I've been so patient and both have sucked ass forever. Peloton... I have considered a loss. It's never going to get back to where I paid for it... I don't see it. I paid like 35 bucks for it and I thought it was a good buy (thanks Motley freaking Fool:( ). LPCN has all the promise... but it's been promising for years and it looks like a math limit bound by zero. I have mentally checked out on both.
1 · Reply
CalculatedSwing
CalculatedSwing Oct. 13 at 5:11 PM
$GLMD 🚀 flexing $20.7M cash fortress after Q2 build-up, slamming 50% into crypto staking & yields for epic degen alpha! Aramchol's biomarker unlock = multi-BILLION$ NASH expansion catalyst, Oct AGM $AKBA $IMUX $LPCN $OCGN – ready to rip! Strap in! 💰🧬📈 #BiotechBulls #DegenMed
2 · Reply
Walkadon
Walkadon Oct. 12 at 6:45 AM
$LPCN Do they have a deal with Teledyne FLIR for all the police helicopter night vision FLIR systems ? That could be a huge market for them.
1 · Reply
Geraldbeak
Geraldbeak Oct. 8 at 1:37 AM
$LPCN The Q4 DSMB is the catalyst to watch for in the near term. No other things matter being that no partnership is likely without a compelling argument. This will be an argument if positive.
1 · Reply
brunoq14
brunoq14 Oct. 7 at 11:42 AM
$LPCN Too heavily invested elsewhere to buy much here at present. Only 3000 shares @ 3.03. I sold all the rest of my shares over $10 when it spiked.
1 · Reply
Tothemoonemoji
Tothemoonemoji Oct. 6 at 10:01 PM
$LPCN Volume starting to creep up. Over 300k shares traded today, compared to our usual 5-10k.
1 · Reply
chiefcoho
chiefcoho Oct. 6 at 1:54 AM
$LPCN let’s break the ceiling!!🙏🙏🙏🙏🙏🙏🙏
0 · Reply
Latest News on LPCN
Lipocine Receives Updated Regulatory Guidance on LPCN 1154

Feb 6, 2025, 8:00 AM EST - 9 months ago

Lipocine Receives Updated Regulatory Guidance on LPCN 1154


Lipocine to Present at 36th Annual Roth Conference

Mar 6, 2024, 8:00 AM EST - 1 year ago

Lipocine to Present at 36th Annual Roth Conference


Lipocine to Present at Biotech Showcase 2024

Dec 19, 2023, 8:00 AM EST - 2 years ago

Lipocine to Present at Biotech Showcase 2024


Pedelco
Pedelco Oct. 27 at 4:51 PM
$LPCN come ✌️
0 · Reply
veseli
veseli Oct. 24 at 2:37 PM
$LPCN Yesterdays prophecy coming true
2 · Reply
veseli
veseli Oct. 15 at 7:28 PM
$LPCN Dead in the water 🤷
2 · Reply
dbatech99
dbatech99 Oct. 13 at 7:59 PM
$AMD Here are the only 2 stinkers I have... $PTON and $LPCN I don't have a large position of each... but I've been so patient and both have sucked ass forever. Peloton... I have considered a loss. It's never going to get back to where I paid for it... I don't see it. I paid like 35 bucks for it and I thought it was a good buy (thanks Motley freaking Fool:( ). LPCN has all the promise... but it's been promising for years and it looks like a math limit bound by zero. I have mentally checked out on both.
1 · Reply
CalculatedSwing
CalculatedSwing Oct. 13 at 5:11 PM
$GLMD 🚀 flexing $20.7M cash fortress after Q2 build-up, slamming 50% into crypto staking & yields for epic degen alpha! Aramchol's biomarker unlock = multi-BILLION$ NASH expansion catalyst, Oct AGM $AKBA $IMUX $LPCN $OCGN – ready to rip! Strap in! 💰🧬📈 #BiotechBulls #DegenMed
2 · Reply
Walkadon
Walkadon Oct. 12 at 6:45 AM
$LPCN Do they have a deal with Teledyne FLIR for all the police helicopter night vision FLIR systems ? That could be a huge market for them.
1 · Reply
Geraldbeak
Geraldbeak Oct. 8 at 1:37 AM
$LPCN The Q4 DSMB is the catalyst to watch for in the near term. No other things matter being that no partnership is likely without a compelling argument. This will be an argument if positive.
1 · Reply
brunoq14
brunoq14 Oct. 7 at 11:42 AM
$LPCN Too heavily invested elsewhere to buy much here at present. Only 3000 shares @ 3.03. I sold all the rest of my shares over $10 when it spiked.
1 · Reply
Tothemoonemoji
Tothemoonemoji Oct. 6 at 10:01 PM
$LPCN Volume starting to creep up. Over 300k shares traded today, compared to our usual 5-10k.
1 · Reply
chiefcoho
chiefcoho Oct. 6 at 1:54 AM
$LPCN let’s break the ceiling!!🙏🙏🙏🙏🙏🙏🙏
0 · Reply
brunoq14
brunoq14 Oct. 5 at 10:25 AM
$LPCN There is an announcement at the trial website about effects of the government shutdown.
1 · Reply
Tothemoonemoji
Tothemoonemoji Oct. 4 at 11:30 PM
$LPCN Afterhours buys yesterday looked pretty decent, almost a 10k share buy at 3.60. I say we get a significant move up this week. Whether it means anything has changed beyond speculation remains to be seen
1 · Reply
Boknow
Boknow Oct. 3 at 4:56 PM
$LPCN In my opinion, $10 or more by January, maybe before, we have a few things going along in the pipeline. Let’s go LPCN
2 · Reply
aah98a
aah98a Oct. 3 at 4:29 PM
$LPCN I Love it! I hope we can run this over $10 a share. Does anyone know when is the safety Board meeting?
1 · Reply
Boknow
Boknow Oct. 3 at 3:23 PM
$LPCN This is priming for a takeoff
0 · Reply
ITF
ITF Oct. 2 at 9:10 AM
$LPCN have we started the climb?
2 · Reply
prismmarketview
prismmarketview Sep. 30 at 7:30 PM
(NASDAQ: $LPCN) Lipocine has announced it is advancing its Phase 3 trial for LPCN-1154, targeting postpartum depression. The move underscores growing confidence in the drug’s therapeutic potential and highlights mental health innovation in women’s health. https://prismmarketview.com/lipocine-advances-phase-3-trial-of-lpcn-1154-for-postpartum-depression/
0 · Reply
JoJo2024
JoJo2024 Sep. 30 at 1:51 PM
Became aware of $LPCN because I owned $SAGE. Since SAGE has the patent rights to brexanolone, how does this impact LPCN? Does lipocine have to license/pay Supernus for using brexanolone?
1 · Reply
brunoq14
brunoq14 Sep. 29 at 5:25 PM
$LPCN Down to about six months, right? Results anticipated in Q2, 26. Now three months past first dosing.
1 · Reply
upNupAlways3
upNupAlways3 Sep. 25 at 4:11 PM
$LPCN time to walking down for accumulation for Data in Q4!!! Fukn market makers!!!
0 · Reply
Tothemoonemoji
Tothemoonemoji Sep. 25 at 12:29 AM
1 · Reply
HoHoHoHum
HoHoHoHum Sep. 19 at 1:12 PM
$LPCN not participating in the rally?
1 · Reply